Prospective Study to Ascertain the Advantages of Adding Neprilysin Inhibitor to Standard Care Among Patients with Congestive Cardiac Failure. (2022). Innovative Journal of Medical and Health Sciences, 12(05), 1903-1909. http://www.innovativejournal.in/index.php/ijmhs/article/view/3440